The new biology of aldosterone

Journal of Endocrinology

Volumn 186, Issue 1, 2005, Pages 1-20

  Connell, John M C ^a   Davies, Eleanor ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOSTEROID; CORTICOTROPIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MINERALOCORTICOID RECEPTOR; POTASSIUM ION;

ADIPOSE TISSUE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CELL NUCLEUS; CENTRAL NERVOUS SYSTEM; CYTOSOL; ELECTROLYTE BALANCE; ENDOTHELIUM CELL; EPITHELIUM CELL; FLUID BALANCE; HEART FAILURE; HOMEOSTASIS; HORMONE RECEPTOR TRANSLOCATION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOALDOSTERONISM; IN VITRO STUDY; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; ZONA GLOMERULOSA;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM; EPITHELIAL CELLS; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIUM; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION; WATER-ELECTROLYTE BALANCE; ZONA GLOMERULOSA;

EID: 22544466731     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06017     Document Type: Review

References (187)

1. Abdelhamid S, Blomer R, Hommel G, Haack D, Lewicka S, Fiegel P & Krumme B 2003 Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study. American Journal of Hypertension 16 522-530.
2. Agarwal MK, Mirshahi F, Mirshahi M & Rostene W 1993 Immunochemical detection of the mineralocorticoid receptor in rat brain. Neuroendocrinology 58 575-580.
3. Aguilera G, Kiss A, Lu A & Camacho C 1996 Regulation of adrenal steroidogenesis during chronic stress. Endocrine Research 22 433-443.
4. Aizman R, Asher C, Fuzesi M, Latter H, Lonai P, Karlish SJD & Carty H 2002 Generation and phenotypic analysis of CHIF knockout mice. American Journal of Physiology Renal Physiology 283 F569-F577.
5. Ajilore OA & Sapolsky RM 1999 In vivo characterization of 11β-hydroxysteroid dehydrogenase in rat hippocampus using glucocorticoid neuroendangerment as an endpoint. Neuroendocrinology 69 138-144.
6. Albiston AL, Obeyesekere VR, Smith RE & Krozowski ZS 1994 Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology 105 11-17.
7. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE & Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 268-275.
8. Bassett MH, White PC & Rainey WE 2004 The regulation of aldosterone synthase expression. Molecular and Cellular Endocrinology 217 67-74.
9. Baulieu EE & Robel P 1990 Neurosteroids: a new brain function? Journal of Steroid Biochemistry and Molecular Biology 37 395-403.
10. Berube D, Luu-The V, Lachance Y, Gagne R & Labrie F 1989 Assignment of the human 30-hydroxysteroid dehydrogenase gene to the p13 band of chromosome 1. Cytogenetics and Cell Genetics 52 199-200.
11. Beyenburg S, Watzka M, Clusmann H, Blumcke I, Bidlingmaier F, Elger CE & Stoffel-Wagner B 2001 Messenger RNA of steroid 21-hydroxylase (CYP21) is expressed in the human hippocampus. Neuroscience Letters 308 111-114.
12. Bird IM, Mason JI & Rainey WE 1994 Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology 134 2468-2474.
13. Bird IM, Pasquarette MM, Rainey WE & Mason JI 1996 Differential control of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells. Journal of Clinical Endocrinology and Metabolism 81 2171-2178.
14. Blazer-Yost BL, Liu X & Helman SI 1998 Hormonal regulation of ENaCs: insulin and aldosterone. American Journal of Physiology - Endocrinology and Metabolism 274 1373-1379.
15. Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, Corvol P, Pascoe L & Soubrier F 1998 Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 32 198-204.
16. Brilla CG & Weber KT 1992 Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. Journal of Laboratory and Clinical Medicine 120 893-901.
17. Brown NJ, Vaughan DE & Fogo AB 2002 Aldosterone and PAI-1: implications for renal injury. Journal of Nephrology 15 230-235.
18. Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ & Parker KL 1997 Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. PNAS 94 11540-11545.
19. + absorption in rats by increasing NHE3 expression of the proximal colon. American Journal of Physiology Cell Physiology 274 C586-C594.
20. Christ M, Meyer C, Sippel K & Wehling M 1995 Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C alpha. Biochemical and Biophysical Research Communications 213 123-129.
21. Chua SC, Szabo P, Vitek A, Grzeschik KH, John M & White PC 1987 Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). PNAS 84 7193-7197.
22. Cicila G, Rapp JR, Wang J-M, St Lezin E, Ng S & Kurtz TW 1993 Linkage of 11β-hydroxylase mutations with altered steroid biosynthesis and blood pressure in Dahl rat. Nature Genetics 3 346-353.
23. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC & Rainey WE 1997 Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Molecular Endocrinology 11 638-649.
24. Coll AP, Challis BG, Yeo GS, Snell K, Piper SJ, Halsall D, Thresher RR & O'Rahilly S 2004 The effects of POMC deficiency on murine adrenal development and responsiveness to ACTH. Endocrinology 145 4721-4727.
25. Conn JW & Louis LH 1956 Primary aldosteronism, a new clinical entity. Annals of Internal Medicine 44 1-15.
26. Connell JMC, Fraser R, MacKenzie SM & Davies E 2003 Essential hypertension and primary aldosteronism-a continuum of disorders of adrenal steroid biosynthesis? Hypertension 41 993-999.
27. Cooke BA 1999 Signal transduction involving cyclic AMP-dependent and cyclic AMP-independent mechanisms in the control of steroidogenesis. Molecular and Cellular Endocrinology 151 25-35.
28. Cozza EN, Vila MC, Acevedo-Duncan M, Farese RV & Gomez-Sanchez CE 1990 Treatment of primary cultures of calf adrenal glomerulosa cells with adrenocorticotropin (ACTH) and phorbol esters: a comparative study of the effects on aldosterone production and ACTH signaling system. Endocrinology 126 2169-2176.
29. Davies E & MacKenzie SM 2003 Extra-adrenal production of corticosteroids. Clinical and Experimental Pharmacology and Physiology 30 437-445.
30. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R & Connell JMC 1999 Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33 703-707.
31. Davies E, Holloway CD, Ingram MC, Friel EC, Inglis GC, Swan L, Hillis WS, Fraser R & Connell JMC 2001 An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clinical Endocrinology 54 813-817.
32. Diaz R, Brown RW & Seckl JR 1998 Distinct ontogeny of glucocorticoid and meniralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions. Journal of Neuroscience 18 2570-2580.
33. Edinger RS, Rokaw MD & Johnson JP 1999 Vasopressin stimulates sodium transport in A6 cells via a phosphatidylinositide 3-kinase-dependent pathway. American Journal of Physiology Renal Physiology 277 F575-F579.
34. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA & Bornstein SR 2003 Human adipocytes secrete mineralocorticoid-releasing factors. PNAS 100 14211-14216.
35. Eisen C, Meyer C, Christ M, Theisen K & Wehling M 1994 Novel membrane receptors for aldosterone in human lymphocytes: a 50 kDa protein on SDS-PAGE. Cellular and Molecular Biology (Noisy-le-grand) 40 351-358.
36. Falkenstein E, Tillmann HC, Christ M, Feuring M & Wehling M 2000 Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacological Reviews 52 513-556.
37. Farman N & Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. American Journal of Physiology Renal Physiology 280 F181-F192.
38. Farman N, Fay M & Cluzeaud F 2003 Cell-specific expression of three members of the FXYD family along the renal tubule. Annals of the New York Academy of Sciences 986 428-436.
39. Freel EM & Connell JM 2004 Mechanisms of hypertension: the expanding role of aldosterone. Journal of the American Society of Nephrology 15 1993-2001.
40. Fuchs-Hammoser R, Schweiger M & Oelkers W 1980 The effect of chronic low-dose infusion of ACTH (1-24) on renin, renin-substrate, aldosterone and other corticosteroids in sodium replete and deplete man. Acta Endocrinology (Copenhagen) 95 198-206.
41. Fullerton MJ & Funder JW 1994 Aldosterone and cardiac fibrosis: in vitro studies. Cardiovascular Research 28 1863-1867.
42. Funder JW 1995 Steroids, hypertension and cardiac fibrosis. Blood Pressure 4 39-42.
43. Funder JW 2004 Aldosterone, mineralocorticoid receptors and vascular inflammation. Molecular and Cellular Endocrinology 217 263-269.
44. Funder JW, Pearce PT, Smith R & Smith IA 1988 Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242 583-585.
45. Furukawa A, Miyatake A, Ohnishi T & Ichikawa Y 1998 Steroidogenic acute regulatory protein (StAR) transcripts constitutively expressed in the adult rat central nervous system: colocalization of StAR, cytochrome P-450 SCC (CYP XTA1), and 3 beta- hydroxysteroid dehydrogenase in the rat brain. Journal of Neurochemistry 71 2231-2238.
46. Garrett MR & Rapp JR 2003 Defining the blood pressure QTL on chromosome 7 in Dahl rats by a 177-kb congenic segment containing CYP11B1. Mammalian Genome 14 268-273.
47. Garty H, Lindzen M, Fuzesi M, Aizman R, Goldshleger R, Asher C & Karlish SJ 2003 A specific functional interaction between CHIF and Na, K-ATPase: role of FXYD proteins in the cellular regulation of the pump. Annals of the New York Academy of Sciences 986 395-400.
48. Geering K, Beguin P, Garty H, Karlish SJ, Fuzesi M, Horisberger JD & Crambert G 2003 FXYD proteins: new tissue-and isoform-specific regulators of Na, K-ATPase. Annals of the New York Academy of Sciences 986 444-448.
49. Gomez-Sanchez EP 1986 Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118 819-823.
50. Gomez-Sanchez EP 1997 Central hypertensive effects of aldosterone. Frontiers in Neuroendocrinology 18 440-462.
51. Gomez-Sanchez EP, Fort CM & Gomez-Sanchez CE 1990a Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. American Journal of Physiology 258 482-484.
52. Gomez-Sanchez EP, Venkataraman MT, Thwaites D & Fort C 1990 b ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. American Journal of Physiology 258 649-653.
53. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Eddleman FC & Gomez-Sanchez EP 1996 Corticosteroid synthesis in the central nervous system. Endocrine Research 22 463-470.
54. Gomez-Sanchez EP, Ahmad N, Romero DG & Gomez-Sanchez CE 2004 Origin of aldosterone in the rat heart. Endocrinology 145 4796-4802.
55. Goodfriend TL & Calhoun DA 2004 Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43 518-524.
56. Goodfriend TL, Egan BM & Kelley DE 1998 Aldosterone in obesity. Endocrine Research 24 789-796.
57. Goodfriend TL, Ball DL, Raff H, Bruder ED, Gardner HW & Spiteller G 2002 Oxidized products of linoleic acid stimulate adrenal steroidogenesis. Endocrine Research 28 325-330.
58. Harvey BJ, Condliffe S & Doolan CM 2001 Sex and salt hormones: rapid effects in epithelia. News in Physiological Sciences 16 174-177.
59. Haseroth K, Gerdes D, Berger S, Feuring M, Gunther A, Herbst C, Christ M & Wehling M 1999 Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor- knockout mice. Biochemical and Biophysical Research Communications 266 257-261.
60. Hautanena A, Lankinen L, Kupari M, Janne OA, Adlercreutz H, Nikkila H & White PC 1998 Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. Journal of Internal Medicine 244 11-18.
61. Holland OB & Carr B 1993 Modulation of aldosterone synthase messenger ribonucleic acid levels by dietary sodium and potassium and by adrenocorticotropin. Endocrinology 132 2666-2673.
62. Inglis GC, Plouin PF, Friel EC, Davies E, Fraser R & Connell JMC 2001 Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome). Clinical Endocrinology 54 725-730.
63. Janiak PC, Lewis SJ & Brody MJ 1990 Role of central mineralocorticoid binding sites in development of hypertension. American Journal of Physiology 259 1025-1034.
64. Jazayeri A & Meyer WJ, III 1989 Mineralocorticoid-induced increase in beta-adrenergic receptors of cultured rat arterial smooth muscle cells. Journal of Steroid Biochemistry 33 987-991.
65. Jung-Testas I, Hu ZY, Baulieu EE & Robel P 1989 Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology 125 2083-2091.
66. Kageyama Y & Bravo EL 1988 Hypertensive mechanisms associated with centrally administered aldosterone in dogs. Hypertension 11 750-753.
67. Karin M 1998 New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93 487-490.
68. Karssen AM, Meijer OC, van der Sant ICJ, Lucassen PJ, de Lange ECM, e Boer AG & e Kloet ER 2001 Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 142 2686-2694.
69. Kayes-Wandover KM & White PC 2000 Steroidogenic enzyme gene expression in the human heart. Journal of Clinical Endocrinology and Metabolism 85 2519-2525.
70. Kennon B, Ingram MC, Friel EC, Anderson NH, MacKenzie SM, Davies L, Shakerdi L, Wallace AM, Fraser R & Connell JM 2004 Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clinical Endocrinology 61 174-181.
71. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB & Knepper MA 1998 The thiazide-sensitive Na-C1 cotransporter is an aldosterone-induced protein. PNAS 95 14552-14557.
72. de Kloet ER, Ratka A, Reul JMHM, Sutanto W & Van Eekelen JAM 1987 Corticosteroid receptor types in brain: regulation and putative function. Annals of the New York Academy of Sciences 512 351-361.
73. Lachance Y, Luu-The V, Verrault H, Dumont M, Berube E, Lablanc G & Labrie F 1991 Structure of the human type II 3β-hydroxysteroid dehydrogenase/5,4 isomerase (3βHSD) gene: adrenal and gonadal specificity. DNA Cell Biology 10 701-711.
74. Lambeth JD, Seybert DW, Lancaster JR, Jr., Salerno JC & Kamin H 1982 Steroidogenic electron transport in adrenal cortex mitochondria. Molecular and Cellular Biochemistry 45 13-31.
75. Lieberman S & Lin YY 2001 Reflections on sterol sidechain cleavage process catalyzed by cytochrome P450(scc). Journal of Steroid Biochemistry and Molecular Biology 78 1-14.
76. Liew D & Krum H 2003 Aldosterone receptor antagonists for hypertension: what do they offer? Drugs 63 1963-1972.
77. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S & Lalouel J-M 1992 A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355 262-265.
78. Lim PO, Jung RT & MacDonald TM 1999 Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. British Journal of Clinical Pharmacology 48 756-760.
79. Lim PO, Jung RT & MacDonald TM 2002 Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity. Journal of Human Hypertension 16 153-158.
80. Lin D, Sugawara T, Strauss JF, Clark BJ, Stocco DM, Saenger P, Rogol A & Miller WL 1995 Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267 1828-1831.
81. Litchfield WR, Anderson BF, Weiss PJ, Lifton RP & Dluhy RG 1998 Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31 445-450.
82. Lombes M, Alfaidy N, Eugene E, Lessana A, Farman N & Bonvalet JP 1995 Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation 92 175-182.
83. Losel R, Schultz A & Wehling M 2004 A quick glance at rapid aldosterone action. Molecular and Cellular Endocrinology 217 137-141.
84. Macdonald JE, Kennedy N & Struthers AD 2004 Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markets in patients with mild heart failure already taking optimal treatment. Heart 90 765-770.
85. MacKenzie SM, Clark CJ, Fraser R, Gomez-Sanchez CE, Connell JM & Davies E 2000a Expression of 11 beta-hydroxylase and aldosterone synthase genes in the rat brain. Journal of Molecular Endocrinology 24 321-328.
86. MacKenzie SM, Clark CJ, Ingram MC, Lai M, Seckl J, Gomez-Sanchez CE, Fraser R, Connell JM & Davies E 2000b Corticosteroid production by fetal rat hippocampal neurons. Endocrine Research 26 531-535.
87. MacKenzie SM, Fraser R, Connell JMC & Davies E 2002a Local renin-angiotensin systems and their interactions with extra-adrenal corticosteroid production. Journal of the Renin - Angiotensin - Aldosterone System 3 214-221.
88. MacKenzie SM, Lai M, Clark CJ, Fraser R, Gómez-Sánchez CE, Seckl JR, Connell JMC & Davies E 2002b 11β-Hydroxylase and aldosterone synthase expression in fetal rat hippocampal neurons. Journal of Molecular Endocrinology 29 319-325.
89. Mason JI 1993 The 3β-hydroxysteroid dehydrogenase gene family of enzymes. Trends in Endocrinology and Metabolism 4 199-203.
90. + channel and decreases its surface expression in Xenopus oocytes. Molecular and Cellular Biochemistry 9 3417-3427.
91. McAllister JM & Hornsby PJ 1988 Dual regulation of 3 beta-hydroxysteroid dehydrogenase, 17 alpha- hydroxylase, and dehydroepiandrosterone sulfotransferase by adenosine 3′,5′-monophosphate and activators of protein kinase C in cultured human adrenocortical cells. Endocrinology 122 2012-2018.
92. Mellon SH, Bair SR & Monis H 1995 P450c11B3 mRNA, transcribed from a third P450c11 gene, is expressed in a tissue-specific, developmentally, and hormonally regulated fashion in the rodent adrenal and encodes a protein with both 11-hydroxylase and 18-hydroxylase activities. Journal of Biological Chemistry 270 1643-1649.
93. Mellon SH, Kushner JA & Vaisse C 1991 Expression and regulation of adrenodoxin and P450 scc mRNA in rodent tissues. DNA and Cell Biology 10 339-347.
94. + exchanger, intracellular calcium levels and vasoconstriction in mesenteric resistance vessels. Endocrinology DOI:10.1210/en.2004-1130.
95. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, Harada E, Nakayama M, Nakamura S, Ito T, Shimasaki Y, Saito Y & Nakao K 2001 Aldosterone production is activated in failing ventricle in humans. Circulation 103 72-77.
96. Montori VM & Young WF, Jr. 2002 Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinology and Metabolism Clinics of North America 31 619-632, xi.
97. Mornet E, Dupont J, Vitek A & White PC 1989 Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). Journal of Biological Chemistry 264 20961-20967.
98. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F & Young WF, Jr. 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. Journal of Clinical Endocrinology and Metabolism 89 1045-1050.
99. Muller J 1987 Regulation of aldosterone biosynthesis. Physiological and clinical aspects. Monographs in Endocrinology 29 1-364.
100. Naray-Fejes-Toth A, Helms MN, Stokes JB & Fejes-Toth G 2004 Regulation of sodium transport in mammalian collecting duct cells by aldosterone-induced kinase, SGK1: structure/function studies. Molecular and Cellular Endocrinology 217 197-202.
101. Oelkers W 1985 Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity. Acta Endocrinologica 108 91-97.
102. Okubo S, Niimura F, Matsusaka T, Fogo A, Hogan BL & Ichikawa I 1998 Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption. Kidney International 53 617-625.
103. Padfield PL 2002 Primary aldosteronism, a common entity? The myth persists. Journal of Human Hypertension 16 159-162.
104. Padfield PL, Brown JJ, Davies D, Fraser R, Lever AF, Morton JJ & Robertson JI 1981 The myth of idiopathic hyperaldosteronism. Lancet 2 83-84.
105. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, Ardaillou R & Soubrier F 1999 Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 34 423-429.
106. de Paula RB, da Silva AA & Hall JE 2004 Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 43 41-47.
107. Pearce D 2003 SGK1 regulation of epithelial sodium transport. Cellular Physiology and Biochemistry 13 13-20.
108. Peysner K, Henry CA & Malvin RL 1990 Central infusion of aldosterone increases blood pressure by mechanisms independent of Na retention. Clinical and Experimental Hypertension A 12 399-414.
109. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J & Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New England Journal of Medicine 341 709-716.
110. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D & Thiyagarajan B 2000 Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 355 1582-1587.
111. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D & Williams GH 2003a Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108 1831-1838.
112. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Rittman R, Hurley S, Kleiman J, Gatlin M & Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators 2003b Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine 348 1309-1321.
113. Qin W, Rudolph AE, Bond BR, Rocha R, Blomme EA, Goellner JJ, Funder JW & McMahon EG 2003 Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circulation Research 93 69-76.
114. Quinn SJ & Williams GH 1988 Regulation of aldosterone secretion. Annual Reviews of Physiology 50 409-426.
115. Reul JMHM & de Kloet ER 1986 Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. Journal of Steroid Biochemistry 24 269-272.
116. Richards AM, Nicholls MG, Espiner EA, Ikram H, Cullens M & Hinton D 1986 Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clinical and Experimental Hypertension A 8 153-166.
117. Robert V, van Thiem N, Cheav SL, Mouas C, Swynghedauw B & Delcayre C 1994 Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension 24 30-36.
118. Robson AC, Leckie CM, Seckl JR & Holmes MC 1998 11b-Hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Molecular Brain Research 61 1-10.
119. Rocha R & Funder JW 2002 The pathophysiology of aldosterone in the cardiovascular system. Annals of the New York Academy of Sciences 970 89-100.
120. Rocha K & Stier CT, Jr. 2001 Pathophysiological effects of aldosterone in cardiovascular tissues. Trends in Endocrinology and Metabolism 12 308-314.
121. Rocha R, Martin-Berger CL, Yang P, Scherrer R, Delyani J & McMahon F 2002 Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 143 4828-4836.
122. Rogerson FM, Brennan FE & Fuller PJ 2004 Mineralocorticoid receptor binding, structure and function. Molecular and Cellular Endocrinology 217 203-212.
123. Romagni P, Rossi F, Guerrini L, Quirini C & Santiemma V 2003 Aldosterone induces contraction of the resistance arteries in man. Atherosclerosis 166 345-349.
124. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C & Pessina AC 1997 Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 95 1471-1478.
125. Sakai RR, Ma LY, Zhang DM, McEwen BS & Fluharty SJ 1996 Intracerebral administration of mineralocorticoid receptor antisense oligonucleotides attenuate adrenal steroid-induced salt appetite in rats. Neuroendocrinology 64 425-429.
126. Samani NJ 1994 Extrarenal renin-angiotensin systems. In Textbook of Hypertension, pp 253-272. Ed JD Swales. Oxford: Blackwell Scientific Publications.
127. Sanne J-L & Krueger KE 1995 Expression of cytochrome P450 side-chain cleavage enzyme and 3β-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization. Journal of Neurochemistry 65 528-536.
128. Sartorato P, Khaldi Y, Lapeyraque AL, Armanini D, Kuhnle U, Salomon R, Caprio M, Viengcharcur S, Lombes M & Zennaro MC 2004 Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism. Molecular and Cellular Endocrinology 217 119-125.
129. Satoh M, Nakamura M, Saitoh H, Satoh H, Akatsu T, Iwasaki J, Masuda T & Hiramori K 2002 Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Clinical Science 102 381-386.
130. Schiffrin EL, Franks DJ & Gutkowska J 1985 Effect of aldosterone on vascular angiotensin II receptors in the rat. Canadian Journal of Physiology and Pharmacology 63 1522-1527.
131. Schmidt BM, Montealegre A, Janson CP, Martin N, Stein-Kemmesies C, Scherhag A, Feuring M, Christ M & Wehling M 1999 Short term cardiovascular effects of aldosterone in healthy male volunteers. Journal of Clinical Endocrinology and Metabolism 84 3528-3533.
132. Seckl JR 1997 11 beta-hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? Frontiers in Neuroendocrinology 18 49-99.
133. Sheppard KE & Autelitano DJ 2002 11β-Hydroxysteroid dehydrogenase 1 transforms 11-dehydrocorticosterone intotranscriptionally active glucocorticoid in neonatal rat heart. Endocrinology 143 198-204.
134. Shinzawa K, Ishibashi S, Murakoshi M, Watanabe K, Kominami S, Kawahara A & Takemori S 1988 Relationship between zonal distribution of microsomal cytochrome P-450s (P-450(17)alpha,lyase and P-450C21) and steroidogenic activities in guinea-pig adrenal cortex. Journal of Endocrinology 119 191-200.
135. Silvestre J-S, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic J-M, Swynghedauw B & Delcayre C 1998a Myocardial production of aldosterone and corticosterone in the rat. Journal of Biological Chemistry 237 4883-4891.
136. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B & Delcayre C 1998b Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. Journal of Biological Chemistry 273 4883-4891.
137. Silvestre J-S, Heymes C, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B & Delcayre C 1999 Activation of cardiac aldosterone production in rat myocardial infarction. Circulation 99 2694-2701.
138. Simard J, Couet J, Durocher F, Labrie Y, Sanchez K, Breton N, Turgeon C & Labrie F 1993 Structure and tissue-specific expression of a novel member of the rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta- HSD) family. The exclusive 3 beta-HSD gene expression in the skin. Journal of Biological Chemistry 268 19659-19668.
139. de Simone G, Tommaselli A, Rossi R, Valentino R, Lauria R, Scopacasa F & Lombardi G 1985 Partial deficiency of adrenal 11β-hydroxylase-a possible cause of primary hypertension. Hypertension 7 613-618.
140. +-dependent 11β-hydroxysteroid dehydrogenase in the human heart. Journal of Molecular and Cellular Cardiology 28 781-787.
141. + concentration. Molecular and Cellular Endocrinology 217 23-26.
142. Spat A & Hunyady L 2004 Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiological Reviews 84 489-539.
143. Stewart PM & Krozowski ZS 1999 11 beta-Hydroxysteroid dehydrogenase. Vitam. Horm. 57 249-324.
144. Stewart PM, Corrie JE, Shackleton CH & Edwards CR 1988 Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. Journal of Clinical Investigation 82 340-349.
145. Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC & Whorwood CB 1996 Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet 347 88-91.
146. Stocco DM 2001a StAR protein and the regulation of steroid hormone biosynthesis. Annual Review of Physiology 63 193-213.
147. Stocco DM 2001b Tracking the role of a star in the sky of the new millennium. Molecular Endocrinology 15 1245-1254.
148. Stockand JD 2002 New ideas about aldosterone signaling in epithelia. American Journal of Physiology Renal Physiology 282 F559-F576.
149. Stockand JD & Meszaros JG 2003 Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. American Journal of Physiology Heart and Circulatory Physiology 284 H176-H184.
150. Stowasser M & Gordon RD 2004 Primary aldosteronism-careful investigation is essential and rewarding. Molecular and Cellular Endocrinology 217 33-39.
151. Stromstedt M & Waterman MR 1995 Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain. Brain Research Molecular Brain Research 34 75-88.
152. Symington T 1969 The adrenal in hypertension. In Functional Pathology of the Human Adrenal Gland, pp 79-80. Edinburgh: E & S Livingstone.
153. + channel. Journal of Biological Chemistry 277 5-8.
154. Taddei S, Virdis A, Mattei P & Salvetti A 1993 Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21 929-933.
155. Tait SA, Tait JF & Coghlan JP 2004 The discovery, isolation and identification of aldosterone: reflections on emerging regulation and function. Molecular and Cellular Endocrinology 217 1-21.
156. Takeda Y 2004 Vascular synthesis of aldosterone: role in hypertension. Molecular and Cellular Endocrinology 217 75-79.
157. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY & Takeda R 1994 Synthesis of corticosterone in the vascular wall. Endocrinology 135 2283-2286.
158. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh F-Y & Takeda R 1995 Production of aldosterone in isolated rat blood vessels. Hypertension 25 170-173.
159. Takeda Y, Miyamori I, Yoneda T, Hatakeyama H, Inaba S, Furukawa K, Mabuchi H & Takeda R 1996 Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. Journal of Clinical Endocrinology and Metabolism 81 2797-2800.
160. Takeda Y, Miyamori I, Inaba S, Furukawa K, Hatakeyama H, Yoneda T, Mabuchi H & Takeda R 1997 Vascular aldosterone in
161. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, Seki T, Demura R & Demura H 1997 Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens. Res. 20 85-90.
162. Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, Kinoshita M, Mannami T, Ogata J & Baba S 2001 Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: The Suita study. Hypertension Research 24 105-109.
163. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T & Hori R 1992 Human P-glycoprotein transports cortisol, aldosterone and dexamethasone, but not progesterone. Journal of Biological Chemistry 267 24248-24252.
164. Ukena K, Usui M, Kohchi C & Tsutsui K 1998 Cytochrome P450 side-chain cleavage enzyme in the cerebellar Purkinje neuron and its neonatal change in rats. Endocrinology 139 137-147.
165. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ & Levy D 2004 Serum aldosterone and the incidence of hypertension in nonhypertensive persons. New England Journal of Medicine 351 33-41.
166. Vinson GP 2003 Adrenocortical zonation and ACTH. Microscopy Research and Technique 61 227-239.
167. Wagner M, Ge Y & Siciliano Wells D 1991 A hybrid cell mapping panel for regional localisation of probes to human chromosome 8. Genomics 10 114-125.
168. Wang W, McClain JM & Zucker IH 1992 Aldosterone reduces baroreceptor discharge in the dog. Hypertension 19 270-277.
169. Weber MA & Purdy RE 1982 Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscle. Life Sciences 30 2009-2017.
170. Wehling M 1997 Specific, nongenomic actions of steroid hormones. Annual Review of Physiology 59 365-393.
171. Wehling M, Spes CH, Win N, Janson CP, Schmidt BMW, Theisen K & Christ M 1998 Rapid cardiovascular action of aldosterone in man. Journal of Clinical Endocrinology and Metabolism 83 3517-3522.
172. White PC 2004 Aldosterone synthase deficiency and related disorders. Molecular and Cellular Endocrinology 217 81-87.
173. White PC, New MI & Dupont B 1986 Structure of human steroid 21-hydroxylase genes. PNAS 83 5111-5115.
174. White PC, Mune T & Agarwal AK 1997 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocrine Reviews 18 135-156.
175. Wu P, Guo Z, Zhang Y, Liu Y, Liang X, Zhang R, Lai W, Takeda Y, Isamu M & Takeda R 1998 Aldosterone overproduction and CYP11B2 mRNA overexpression in vessels of spontaneously hypertensive rats. Hormone Research 50 28-31.
176. Wulff P, Vallon V, Huang DY, Volki H, Yu F, Richter K, Jansen M, Schlunz M, Klingel K, Loffing J et al. 2002 impared renal Na(+) retention in the sgk1-knockout mouse. Journal of Clinical Investigation 110 1263-1268.
177. Ye P, Kenyon CJ, MacKenzie SM, Seckl JR, Fraser R, Connell JMC & Davies E 2003 Regulation of aldosterone synthase gene expression in the rat adrenal gland and central nervous system by sodium and angiotensin II. Endocrinology 144 3321-3328.
178. Yee KM & Struthers AD 1998 Aldosterone blunts the baroreflex response in man. Clinical Science 95 687-692.
179. Yoshida A, Nishikawa T, Tamura Y & Yoshida S 1991 ACTH-induced inhibition of the action of angiotensin II in bovine zona glomerulosa cells. A modulatory effect of cyclic AMP on the angiotensin II receptor. Journal of Biological Chemistry 266 4288-4294.
180. Young M & Funder JW 2000 Aldosterone and the heart. Trends in Endocrinology and Metabolism 11 224-226.
181. Young M & Funder JW 2004 Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone/salt-treated rats. Endocrinology 145 3153-3157.
182. Young M, Head G & Funder J 1996 Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. American Journal of Physiology 269 657-662.
183. Young MJ, Clyne CD, Cole TJ & Funder JW 2001 Cardiac steroidogenesis in the normal and failing heart. Journal of Clinical Endocrinology and Metabolism 86 5121-5126.
184. Young MJ, Moussa L, Dilley R & Funder JW 2003 Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11β-hydroxysteroid dehydrogenase inactivation. Endocrinology 144 1121-1125.
185. Young WF, Jr. 2003 Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 144 2208-2213.
186. Zennaro MC & Lombes M 2004 Mineralocorticoid resistance. Trends in Endocrinology and Metabolism 15 264-270.
187. Zhou MY, Gomez-Sanchez EP, Foecking MF & Gomez-Sanchez CE 1995 Cloning and expression of the rat adrenal cytochrome P-450 11B3 (CYP11B3) enzyme cDNA: preferential 18-hydroxylation over 11 beta- hydroxylation of DOC. Molecular and Cellular Endocrinology 114 137-145.